Medical Encyclopedia › A › Ankylosing spondylitis
Ankylosing spondylitis is a chronic inflammatory rheumatic disease that mainly affects the spine and the sacroiliac joints. Today the term axial spondyloarthritis is generally used. Typical is low back pain that is worst at night and in the morning and improves with movement. It usually begins before the age of 45. Exercise and medicines can control symptoms and inflammation well.
Overview
In axial spondyloarthritis, the immune system attacks tissue of the spine and the sacroiliac joints (sacroiliitis). Over time, inflammation can lead to new bone formation so that parts of the spine stiffen. Forms with changes already visible on X-ray are distinguished from early forms seen only on MRI. Men and women are affected; in women the disease is often recognised later.
Symptoms
The key symptom is inflammatory back pain: it starts gradually, lasts more than three months, is worst in the second half of the night and in the morning, comes with morning stiffness and improves with movement, not rest. Tendon attachments, for example at the heel, are often painful, or individual joints swell. Inflammation of the iris (anterior uveitis), psoriasis or inflammatory bowel disease such as Crohn’s disease can also occur.
Causes
The exact cause is unknown. Inherited susceptibility plays a major role: most people affected carry the tissue marker HLA-B27. However, only a few people with this marker develop the disease. Smoking promotes progression of stiffening.
Diagnosis
Because the back pain is non-specific, diagnosis often takes years. Clues are the typical pain pattern, inflammation markers such as CRP and a positive HLA-B27 test. MRI shows early inflammation of the sacroiliac joints; later changes are also visible on X-ray. The diagnosis is usually made by a rheumatologist.
Treatment
The cornerstones are regular exercise and physiotherapy, such as group exercise programmes. First-choice medicines are NSAIDs. If they are not enough, biologics such as TNF inhibitors, for example adalimumab, or interleukin-17 inhibitors such as secukinumab are options, as are JAK inhibitors. Conventional disease-modifying drugs such as methotrexate have little effect on spinal symptoms, and corticosteroids are not used long term. Surgery is needed only for severe stiffening or damaged hip joints.
Outlook
The course varies greatly and often comes in flares. With treatment, many people lead a largely normal life. Consistent exercise, not smoking and regular check-ups are important, as osteoporosis can develop over time.
Frequently asked questions
How do you recognise ankylosing spondylitis?
Typical is low back pain that starts gradually, lasts more than three months, is worst at night and in the morning and improves with movement. Assessment by a rheumatologist includes blood tests and imaging.
Is ankylosing spondylitis hereditary?
A susceptibility is inherited, mainly through the HLA-B27 marker. However, the disease develops in only a small proportion of carriers.
Which exercise is good for ankylosing spondylitis?
Activities that promote mobility and posture are suitable, such as swimming, Nordic walking, cycling and targeted exercises. Regularity matters more than intensity.
Related terms
- Sacroiliitis
- Sacroiliac joint
- HLA-B27
- Anterior uveitis
- Psoriatic arthritis
- Rheumatoid arthritis
- NSAIDs
- Biologics
Test your knowledge: questions on rheumatism, the musculoskeletal system and more – from beginner to exam level.
Go to the Medical QuizSources
- Ramiro S et al.: ASAS-EULAR recommendations for the management of axial spondyloarthritis – 2022 update (Annals of the Rheumatic Diseases, 2023)
- NICE guideline NG65: Spondyloarthritis in over 16s – diagnosis and management
- S3 guideline Axial spondyloarthritis including ankylosing spondylitis and early forms (German Society for Rheumatology, DGRh; AWMF)
This entry is for general information only and does not replace medical advice. Last updated: November 2026.